ICD-10-CM code · FY2027
I82.461 Acute embolism and thrombosis of right calf muscular vein
BillableValid for claims as a specific diagnosis code
About I82.461
- Code
- I82.461
- Billable
- Yes
- Short description
- Acute embolism and thrombosis of right calf muscular vein
- Category
- I82 Other venous embolism and thrombosis
- Block
- I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified
- Chapter
- 9 Diseases of the circulatory system
- Code set
- FY2027, October 1, 2026 to September 30, 2027
EvidencePulse™by 2 Minute Medicine®
Go deeper into venous thrombosis.
Ask about the latest evidence, the landmark trials or what guidelines recommend, with every study cited. No ads, no sponsored answers.
Coding notes for I82.461
No notes of its own; the notes below apply from the codes above it.
Also applies, from I82 Other venous embolism and thrombosis
Excludes2 Not part of this condition, but a patient can have both: report both codes when both apply.
Code first Report the underlying condition's code before this one.
Chapter 9 notes (apply to every code in it)
Excludes2 Not part of this condition, but a patient can have both: report both codes when both apply.
- certain conditions originating in the perinatal period (P04-P96)
- certain infectious and parasitic diseases (A00-B99)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
- systemic connective tissue disorders (M30-M36)
- transient cerebral ischemic attacks and related syndromes (G45.-)
Related codes in I82.46
Latest research on venous thrombosis
- Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk
- #VisualAbstract: Reduced-Dose was Not Non-Inferior to Full-Dose Direct Oral Anticoagulants in Venous Thromboembolism Patients
- #VisualAbstract: Enoxaparin versus Placebo to Prevent Symptomatic Venous Thromboembolism in Hospitalized Older Adult Medical Patients
- Indefinite anticoagulation for unprovoked venous thromboembolism is not cost-effective
- Low-dose low-molecular weight heparin comparable to intermediate-dose for risk of venous thromboembolism in peripartum women
Landmark trials from 2MM Classics
- Compression ultrasound identifies proximal deep venous thrombosis with high sensitivity and specificity [Classics Series]
- Transjugular intrahepatic portosystemic shunt effective in preventing recurrent variceal hemorrhage [Classics Series]
- Hepatic arterial phase imaging more sensitive than portal venous phase in the detection of hepatic lesions and arterioportal shunting [Classics Series]
2MM+
Read the research behind every diagnosis
2MM+ gives you every study summary in full, Classics downloads of the landmark trials, EvidencePulse and HypeCheck, and ad-free reading.
See 2MM+ plansICD-10-CM FY2027 code set, as published by the CDC National Center for Health Statistics (NCHS) and CMS, effective October 1, 2026 to September 30, 2027. Codes, titles and notes are shown as published. Check payer rules and the official guidelines before billing. This page is not medical advice.
Get the app